Health Catalyst (NASDAQ:HCAT) Price Target Lowered to $4.50 at Stifel Nicolaus

Key Points

• Stifel Nicolaus has reduced its target price for Health Catalyst (NASDAQ: HCAT) from $5.50 to $4.50, maintaining a "hold" rating, which indicates a potential upside of 40.41% from the current stock price.
• Health Catalyst's stock has seen a significant decline, trading down 13.1% and closing at $3.21 during the last trading session, with a recent 12-month low of $2.82.
• Institutional investors own 85% of Health Catalyst, with notable recent acquisitions by firms such as ExodusPoint Capital Management and Wells Fargo, indicating ongoing interest in the stock despite its challenges.

Health Catalyst (NASDAQ:HCAT - Free Report) had its price target lowered by Stifel Nicolaus from $5.50 to $4.50 in a research note published on Friday,Benzinga reports. Stifel Nicolaus currently has a hold rating on the stock.

A number of other equities research analysts also recently weighed in on the company. Cantor Fitzgerald restated a "neutral" rating and set a $4.00 price target (down previously from $9.00) on shares of Health Catalyst in a research report on Friday. BTIG Research downgraded Health Catalyst from a "buy" rating to a "neutral" rating in a research report on Tuesday, June 17th. KeyCorp lowered their price target on Health Catalyst from $7.00 to $5.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 16th. Citigroup lowered their price target on Health Catalyst from $7.00 to $6.50 and set a "buy" rating on the stock in a research report on Friday, April 25th. Finally, Evercore ISI lowered their price target on Health Catalyst from $5.00 to $4.00 and set an "in-line" rating on the stock in a research report on Wednesday, July 9th. Seven equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus target price of $6.55.

Health Catalyst Price Performance

NASDAQ HCAT traded down $0.86 during trading hours on Friday, reaching $2.83. 3,211,344 shares of the stock traded hands, compared to its average volume of 485,329. The stock has a 50 day simple moving average of $3.84 and a two-hundred day simple moving average of $4.26. Health Catalyst has a 1 year low of $2.80 and a 1 year high of $9.24. The company has a debt-to-equity ratio of 0.40, a current ratio of 1.24 and a quick ratio of 1.24. The company has a market cap of $196.97 million, a price-to-earnings ratio of -1.87 and a beta of 1.46.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of HCAT. Group One Trading LLC increased its holdings in Health Catalyst by 107.6% during the 4th quarter. Group One Trading LLC now owns 4,360 shares of the company's stock valued at $31,000 after purchasing an additional 2,260 shares during the period. Divergent Planning LLC purchased a new position in Health Catalyst during the 2nd quarter valued at about $45,000. Focus Partners Wealth purchased a new position in Health Catalyst during the 1st quarter valued at about $46,000. XTX Topco Ltd purchased a new position in Health Catalyst during the 1st quarter valued at about $54,000. Finally, Aquatic Capital Management LLC purchased a new position in Health Catalyst during the 4th quarter valued at about $63,000. Hedge funds and other institutional investors own 85.00% of the company's stock.

About Health Catalyst

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.